In this episode of ETF Battles you’ll watch an audience requested triple-header between the ARK Genomic Revolution ETF (ARKG), Global X Genomics & Biotechnology ETF (GNOM) and iShares Genomics Immunology & Healthcare ETF (IDNA).
The search for therapies tackling chronic illnesses like cancer, diabetes and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.
Ron DeLegge @ETFguide referees this triple-header contest between water ETFs with guest judges Mike Akins from ETF Action and Jessica Ferringer from ETF.com sharing their research insights.
Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category. Find out who wins the battle!
ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. If you’re ready for a bold trade, visit http://www.Direxion.com
Get in touch with our judges:
–YOUR RESOURCES FROM RON–
Free ETF Guides https://tinyurl.com/4uvfx4m7
Get help with your investing habits https://tinyurl.com/2xrpbzz8
Enroll in online classes built for investors https://tinyurl.com/ewn3mh9v
Get feedback on your portfolio’s risk https://tinyurl.com/cz4ahj52
Check your investment performance https://tinyurl.com/cz4ahj52
60 Smart Ways to Retire Better https://60-smart-ways.etfguide.com/
–LISTEN TO ETF BATTLES–
3) Amazon Music
4) Google Podcasts
#Genomics #BiotechETF #BiotechStocks